Adarza: Nicklaus: Adarza maintains its momentum with pivot to COVID-19 research
Maryland Heights firm was ready to launch with a focus on cancer, but quickly came up with test for coronavirus antibodies
Read full article »
Adarza develops a biomarker detection platform that identifies proteins and genetic markers in medical samples such as blood.
Read more